Research suggests that Chyawanprash has a long traditional history of use for respiratory health support, though the clinical evidence directly substantiating these benefits remains limited. A 2022 review article examining human clinical trial data found that despite Chyawanprash being one of the most widely trusted Ayurvedic preparations, the body of rigorous scientific evidence supporting its respiratory health claims is surprisingly sparse. The available evidence is characterized as mixed, with the review identifying notable gaps in the research that have yet to be addressed by well-designed human studies. Readers should be aware that traditional use and popularity do not substitute for robust clinical trial evidence, and more high-quality research is needed before strong conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Golden Ager Chyawanprash with Meager Evidential Base from Human Clinical Trials. | Other | 2022 | Mixed | 100 |